Cargando…
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study
SIMPLE SUMMARY: The PI3K-AKT-mTOR pathway is dysregulated in 70% of head and neck squamous cell carcinoma (HNSCC) and linked to the tumor microenvironment. This weekly induction treatment combined the mTOR inhibitor everolimus with carboplatin-paclitaxel chemotherapy for locally advanced T3-4/N0-3 H...
Autores principales: | Evrard, Diane, Dumont, Clément, Gatineau, Michel, Delord, Jean-Pierre, Fayette, Jérôme, Dreyer, Chantal, Tijeras-Raballand, Annemilaï, de Gramont, Armand, Delattre, Jean-François, Granier, Muriel, Aissat, Nasredine, Garcia-Larnicol, Marie-Line, Slimane, Khemaies, Chibaudel, Benoist, Raymond, Eric, Le Tourneau, Christophe, Faivre, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496893/ https://www.ncbi.nlm.nih.gov/pubmed/36139669 http://dx.doi.org/10.3390/cancers14184509 |
Ejemplares similares
-
Targeting cancer cell metabolism in pancreatic adenocarcinoma
por: Cohen, Romain, et al.
Publicado: (2015) -
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
por: Neuzillet, Cindy, et al.
Publicado: (2013) -
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
por: Serova, Maria, et al.
Publicado: (2015) -
Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma
por: Santos, C D, et al.
Publicado: (2015) -
Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
por: Boilève, Alice, et al.
Publicado: (2021)